Group 1 - The core viewpoint of the article highlights that Spring Medical's stock price closed at 14.65 yuan, up 8.04%, with a rolling PE ratio of 44.96, marking a new low in 72 days, and a total market capitalization of 5.619 billion yuan [1] - The average PE ratio for the medical device industry is 46.46, with a median of 33.07, placing Spring Medical at the 85th position in the industry ranking [1] - As of February 28, 2025, Spring Medical has 6,666 shareholders, a decrease of 247 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Group 2 - Spring Medical specializes in the research, production, and sales of implantable orthopedic medical devices, including standard joint prostheses and customized joint prostheses [1] - The company was recognized as a champion enterprise in the artificial joint prosthesis manufacturing industry by the Ministry of Industry and Information Technology in 2024 [1] - In the latest financial report for 2024, Spring Medical achieved an operating income of 806 million yuan, a year-on-year decrease of 33.32%, and a net profit of 125 million yuan, down 55.01%, with a gross profit margin of 66.63% [1]
春立医疗收盘上涨8.04%,滚动市盈率44.96倍,总市值56.19亿元